Dursun Hüseyin, Gönençer Jale Zeynep, Karabay Özalp, Erdal Abidin Cenk, Kaya Dayimi
Department of Cardiology, Dokuz Eylül University School of Medicine, İzmir, Turkey.
Department of Cardiovascular Surgery, Dokuz Eylül University School of Medicine, İzmir, Turkey.
Balkan Med J. 2016 May;33(3):357-9. doi: 10.5152/balkanmedj.2016.150601. Epub 2016 May 1.
Single coronary artery is a rare congenital coronary artery anomaly with the incidence of approximately 0.03%-0.05%. Its coexistence with severe aortic stenosis (AS) is even rarer. Patients who undergo transcatheter aortic valve implantation (TAVI) have a risk of coronary obstruction (1%) which will be more lethal when the origin of the coronary artery is single.
An 81 year-old female was referred to our institution for severe AS. Her coronary angiography revealed a single coronary artery originating from right sinus of valsalva. Since the patient had a high risk for aortic valve surgery, the cardiac team decided to perform transfemoral TAVI with a self-expandable valve.
We presented a successful case of TAVI with Medtronic CoreValve (Medtronic; Minnesota, USA) in a patient with single coronary artery after discussing the base of our strategy for preferring self-expandable valve. To the best of our knowledge, this is the second case of CoreValve implantation in such a patient in the literature. We suggest that the self-expandable valve may be the first choice in these patients because of its recapturable design.
单支冠状动脉是一种罕见的先天性冠状动脉异常,发病率约为0.03%-0.05%。它与严重主动脉瓣狭窄(AS)并存的情况更为罕见。接受经导管主动脉瓣植入术(TAVI)的患者有冠状动脉阻塞的风险(1%),而当冠状动脉起源为单支时,这种风险将更具致命性。
一名81岁女性因严重AS被转诊至我院。她的冠状动脉造影显示单支冠状动脉起源于主动脉窦右窦。由于该患者接受主动脉瓣手术的风险较高,心脏团队决定使用自膨胀瓣膜行经股动脉TAVI。
在讨论了我们选择自膨胀瓣膜策略的依据后,我们报告了一例使用美敦力CoreValve(美敦力公司;美国明尼苏达州)对单支冠状动脉患者成功进行TAVI的病例。据我们所知,这是文献中该类患者第二例CoreValve植入病例。我们建议,由于其可回收设计,自膨胀瓣膜可能是这些患者的首选。